Enhanced potency of cell-based therapy for ischemic tissue repair using an injectable bioactive epitope presenting nanofiber support matrix

Journal of Molecular and Cellular Cardiology

Volumn 74, Issue , 2014, Pages 231-239

  Tongers, Jörn ^a,c   Webber, Matthew J ^a   Vaughan, Erin E ^a   Sleep, Eduard ^a   Renault, Marie Ange ^a   Roncalli, Jerome G ^a   Klyachko, Ekaterina ^a   Thorne, Tina ^a   Yu, Yang ^a   Marquardt, Katja Theres ^a,c   Kamide, Christine E ^a   Ito, Aiko ^a   Misener, Sol ^a   Millay, Meredith ^a   Liu, Ting ^a   Jujo, Kentaro ^a   Qin, Gangjian ^a   Losordo, Douglas W ^a   Stupp, Samuel I ^a,b   Kishore, Raj ^a,d  

^a NORTHWESTERN UNIVERSITY   (United States)

^b Northwestern University   (United States)

^c HANNOVER MEDICAL SCHOOL   (Germany)

^d TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Angiogenesis; Biomaterials; Cell therapy; Microcirculation; Nanomedicine; Regenerative medicine

Indexed keywords

EPITOPE; FIBRONECTIN; FOCAL ADHESION KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; NANOFIBER; BIOMATERIAL; INTEGRIN; PEPTIDE; PROTEIN BINDING;

AMPUTATION; ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BONE MARROW CELL; BONE MARROW DERIVED PRO ANGIOGENIC CELL; CAPILLARY DENSITY; CELL ADHESION; CELL PROLIFERATION; CELL THERAPY; CONTROLLED STUDY; FEASIBILITY STUDY; IN VITRO STUDY; IN VIVO STUDY; LEG ISCHEMIA; LIMB PERFUSION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; THERAPY EFFECT; TISSUE NECROSIS; TISSUE REPAIR; ANIMAL; BIOLOGICAL THERAPY; CELL SURVIVAL; CHEMISTRY; CYTOLOGY; DRUG EFFECTS; GENE EXPRESSION; GENETICS; HINDLIMB; INJURIES; ISCHEMIA; METABOLISM; PATHOLOGY; PROCEDURES; SYNTHESIS; VASCULARIZATION;

ANIMALS; BIOCOMPATIBLE MATERIALS; BONE MARROW CELLS; CELL SURVIVAL; CELL- AND TISSUE-BASED THERAPY; EPITOPES; FIBRONECTINS; GENE EXPRESSION; HINDLIMB; INTEGRINS; ISCHEMIA; MALE; MICE; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; NANOFIBERS; NEOVASCULARIZATION, PHYSIOLOGIC; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PEPTIDES; PROTEIN BINDING;

EID: 84904726425     PISSN: 00222828     EISSN: 10958584     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2014.05.017     Document Type: Article

References (44)

1. Go A.S., Mozaffarian D., Roger V.L., Benjamin E.J., Berry J.D., Borden W.B., et al. Heart disease and stroke statistics-2013 update: a report from the American Heart Association. Circulation 2013, 127(1):e6-e245.
2. Abdel-Latif A., Bolli R., Tleyjeh I.M., Montori V.M., Perin E.C., Hornung C.A., et al. Adult bone marrow-derived cells for cardiac repair: a systematic review and meta-analysis. Arch Intern Med 2007, 167(10):989-997.
3. Lipinski M.J., Biondi-Zoccai G.G., Abbate A., Khianey R., Sheiban I., Bartunek J., et al. Impact of intracoronary cell therapy on left ventricular function in the setting of acute myocardial infarction: a collaborative systematic review and meta-analysis of controlled clinical trials. J Am Coll Cardiol 2007, 50(18):1761-1767.
4. Martin-Rendon E., Brunskill S.J., Hyde C.J., Stanworth S.J., Mathur A., Watt S.M. Autologous bone marrow stem cells to treat acute myocardial infarction: a systematic review. Eur Heart J 2008, 29(15):1807-1818.
5. + cell therapy for refractory angina. Circ Res 2011, 109(4):428-436.
6. Tateishi-Yuyama E., Matsubara H., Murohara T., Ikeda U., Shintani S., Masaki H., et al. Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: a pilot study and a randomised controlled trial. Lancet 2002, 360(9331):427-435.
7. + cell therapy to explore endpoint selection and timing in patients with critical limb ischemia. Circ J 2014, 78(92):490-501.
8. Bartunek J., Dimmeler S., Drexler H., Fernandez-Aviles F., Galinanes M., Janssens S., et al. The consensus of the task force of the European Society of Cardiology concerning the clinical investigation of the use of autologous adult stem cells for repair of the heart. Eur Heart J 2006, 27(11):1338-1340.
9. Tongers J., Losordo D.W., Landmesser U. Stem and progenitor cell-based therapy in ischaemic heart disease: promise, uncertainties, and challenges. Eur Heart J 2011, 32(10):1197-1206.
10. Aicher A., Brenner W., Zuhayra M., Badorff C., Massoudi S., Assmus B., et al. Assessment of the tissue distribution of transplanted human endothelial progenitor cells by radioactive labeling. Circulation 2003, 107(16):2134-2139.
11. + hematopoietic progenitor cells in a rat myocardial infarction model. J Nucl Med 2004, 45(3):512-518.
12. Hofmann M., Wollert K.C., Meyer G.P., Menke A., Arseniev L., Hertenstein B., et al. Monitoring of bone marrow cell homing into the infarcted human myocardium. Circulation 2005, 111(17):2198-2202.
13. + progenitor cells intracoronary injection in the chronic phase of myocardial infarction. J Cardiovasc Pharmacol 2009, 53(6):480-485.
14. Schachinger V., Aicher A., Dobert N., Rover R., Diener J., Fichtlscherer S., et al. Pilot trial on determinants of progenitor cell recruitment to the infarcted human myocardium. Circulation 2008, 118(14):1425-1432.
15. Hill J.M., Zalos G., Halcox J.P., Schenke W.H., Waclawiw M.A., Quyyumi A.A., et al. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med 2003, 348(7):593-600.
16. Vasa M., Fichtlscherer S., Aicher A., Adler K., Urbich C., Martin H., et al. Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circ Res 2001, 89(1):E1-E7.
17. Heeschen C., Lehmann R., Honold J., Assmus B., Aicher A., Walter D.H., et al. Profoundly reduced neovascularization capacity of bone marrow mononuclear cells derived from patients with chronic ischemic heart disease. Circulation 2004, 109(13):1615-1622.
18. Balsam L.B., Wagers A.J., Christensen J.L., Kofidis T., Weissman I.L., Robbins R.C. Haematopoietic stem cells adopt mature haematopoietic fates in ischaemic myocardium. Nature 2004, 428(6983):668-673.
19. Zhang M., Methot D., Poppa V., Fujio Y., Walsh K., Murry C.E. Cardiomyocyte grafting for cardiac repair: graft cell death and anti-death strategies. J Mol Cell Cardiol 2001, 33(5):907-921.
20. Assmus B., Honold J., Schachinger V., Britten M.B., Fischer-Rasokat U., Lehmann R., et al. Transcoronary transplantation of progenitor cells after myocardial infarction. N Engl J Med 2006, 355(12):1222-1232.
21. Mooney D.J., Vandenburgh H. Cell delivery mechanisms for tissue repair. Cell Stem Cell 2008, 2(3):205-213.
22. Segers V.F., Lee R.T. Biomaterials to enhance stem cell function in the heart. Circ Res 2011, 109(8):910-922.
23. Hartgerink J.D., Beniash E., Stupp S.I. Self-assembly and mineralization of peptide-amphiphile nanofibers. Science 2001, 294(5547):1684-1688.
24. Webber M.J., Kessler J.A., Stupp S.I. Emerging peptide nanomedicine to regenerate tissues and organs. J Intern Med 2010, 267(1):71-88.
25. Webber M.J., Berns E.J., Stupp S.I. Supramolecular nanofibers of peptide amphiphiles for medicine. Isr J Chem 2013, 53(8):530-554.
26. Lee S.S., Huang B.J., Kaltz S.R., Sur S., Newcomb C.J., Stock S.R., et al. Bone regeneration with low dose BMP-2 amplified by biomimetic supramolecular nanofibers within collagen scaffolds. Biomaterials 2013, 34(2):452-459.
27. Shah R.N., Shah N.A., Del Rosario Lim M.M., Hsieh C., Nuber G., Stupp S.I. Supramolecular design of self-assembling nanofibers for cartilage regeneration. Proc Natl Acad Sci U S A 2010, 107(8):3293-3298.
28. Tysseling-Mattiace V.M., Sahni V., Niece K.L., Birch D., Czeisler C., Fehlings M.G., et al. Self-assembling nanofibers inhibit glial scar formation and promote axon elongation after spinal cord injury. J Neurosci 2008, 28(14):3814-3823.
29. Cui H., Webber M.J., Stupp S.I. Self-assembly of peptide amphiphiles: from molecules to nanostructures to biomaterials. Biopolymers 2010, 94(1):1-18.
30. Webber M.J., Tongers J., Renault M.A., Roncalli J.G., Losordo D.W., Stupp S.I. Development of bioactive peptide amphiphiles for therapeutic cell delivery. Acta Biomater 2010, 6(1):3-11.
31. Webber M.J., Han X., Murthy S.N., Rajangam K., Stupp S.I., Lomasney J.W. Capturing the stem cell paracrine effect using heparin-presenting nanofibres to treat cardiovascular diseases. J Tissue Eng Regen Med 2010, 4(8):600-610.
32. Webber M.J., Tongers J., Newcomb C.J., Marquardt K.T., Bauersachs J., Losordo D.W., et al. Supramolecular nanostructures that mimic VEGF as a strategy for ischemic tissue repair. Proc Natl Acad Sci U S A 2011, 108(33):13438-13443.
33. Ghanaati S., Webber M.J., Unger R.E., Orth C., Hulvat J.F., Kiehna S.E., et al. Dynamic in vivo biocompatibility of angiogenic peptide amphiphile nanofibers. Biomaterials 2009, 30(31):6202-6212.
34. Giancotti F.G., Ruoslahti E. Integrin signaling. Science 1999, 285(5430):1028-1032.
35. Pierschbacher M.D., Ruoslahti E. Cell attachment activity of fibronectin can be duplicated by small synthetic fragments of the molecule. Nature 1984, 309(5963):30-33.
36. Couffinhal T., Silver M., Zheng L.P., Kearney M., Witzenbichler B., Isner J.M. Mouse model of angiogenesis. Am J Pathol 1998, 152(6):1667-1679.
37. Heil M., Ziegelhoeffer T., Wagner S., Fernandez B., Helisch A., Martin S., et al. Collateral artery growth (arteriogenesis) after experimental arterial occlusion is impaired in mice lacking CC-chemokine receptor-2. Circ Res 2004, 94(5):671-677.
38. Tateno K., Minamino T., Toko H., Akazawa H., Shimizu N., Takeda S., et al. Critical roles of muscle-secreted angiogenic factors in therapeutic neovascularization. Circ Res 2006, 98(9):1194-1202.
39. Tanaka M., Swijnenburg R.J., Gunawan F., Cao Y.A., Yang Y., Caffarelli A.D., et al. In vivo visualization of cardiac allograft rejection and trafficking passenger leukocytes using bioluminescence imaging. Circulation 2005, 112(9 Suppl.):I105-I110.
40. Storrie H., Guler M.O., Abu-Amara S.N., Volberg T., Rao M., Geiger B., et al. Supramolecular crafting of cell adhesion. Biomaterials 2007, 28(31):4608-4618.
41. Niece K.L., Hartgerink J.D., Donners J.J., Stupp S.I. Self-assembly combining two bioactive peptide-amphiphile molecules into nanofibers by electrostatic attraction. J Am Chem Soc 2003, 125(24):7146-7147.
42. Discher D.E., Mooney D.J., Zandstra P.W. Growth factors, matrices, and forces combine and control stem cells. Science 2009, 324(5935):1673-1677.
43. Pashuck E.T., Cui H., Stupp S.I. Tuning supramolecular rigidity of peptide fibers through molecular structure. J Am Chem Soc 2010, 132(17):6041-6046.
44. Anderson J.M., Rodriguez A., Chang D.T. Foreign body reaction to biomaterials. Semin Immunol 2008, 20(2):86-100.